INVESTOR SEARCH Website

Home >> Investor >> Regulatory Compliance REGULATORY COMPLIANCE 2009-10 Quarterly Compliance Report on Corporate Governance (Clause 49) Details of Revocation of certain securities pledged by relative of the promoter - Disclosure under regulation 8A(4) Details of shares pledged by relative of promoter, disclosure under section 8A(4) Details of shares pledged by relative of promoter - Disclosure under Regulation 8A(2) & 8A(3) of SEBI Board of Directors meeting on 28-Oct-09 to consider Q2 2009-10 Shareholding in terms of Regulation 8(3) of SEBI (SAST) regulations 1997 Expiry of HSR waiting period in U.S. for Taro Tender Offer Disclosure under Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Compliance with Clause 49 of listing agreement Details of Shareholding, in terms of Regulation 8(3) of SEBI Regulations 1997 2008-09 Report on proceedings of 17th AGM held on Sept 11, 2009 Notice of Annual General Meeting Form Of Communication For Waiving /Forgoing Right To Receive The Dividend From The Company Outcome of Board meeting on May 30, 2009 US FDA Approval for acquisition of Shares of Taro Extension of Tender Offer for purchase of Taro shares Compliance with Clause 49 of listing agreement Details of the shares revoked by the promoter or every person forming part of the promoter group Letter to Stock Exchange regarding shares Pledgesd by Promotor group Board of Directors meet on Jan 30, 2009 Compliance with clause 49 of the Listing agreement for quarter ended 30th Sept 2008 2007-08 Notice of Annual General Meeting Form for Waiver-Forgoing Dividend Publication of Audited Annual Accounts for the year ended 31st March, 2008 Compliance with Regulation 8(3) of SEBI (SAST) Regulations,1997 19.04.2008 Compliance with Clause 49 of the Listing Agreement 12.04.2008 Allotnment of Equity shares against conversion of further FCCBs of Sun Pharmaceutical Industries Ltd. Letter to the stock exchange: redemption of preference shares Circular to preference shareholders 2006-07 Approval for demerger of SPIL & SPARC Compliance with Regulation 8(3) of SEBI (SAST) Regulations,1997 17.04.2007 Memorandum of Association Board meeting: Record date for Interim Dividend Notice of Annual General Meeting Form of Redemption Request for Preference Shares Closed period for bonds 2005-06 No objection to demerger from NSE No objection to demerger from BSE Notice to equity shareholders - demerger Notice to preference shareholders- demerger Notice to secured creditors- demerger Notice to unsecured creditors- demerger Notice to FCCB holders- demerger Code of Conduct Preference share notice: Phlox Pharma merger 2004-05 Information on additional launch of FCCBs Buyback of 6% Cumulative Redeemable Preference Shares Letter to the stock exchange for result correction Equity share notice: Phlox Pharma merger Preference share notice: Phlox Pharma merger Letter to the Stock Exchange Notice of Extra Ordinary General Meeting 2003-04 Notice for AGM Notice for the meeting of preference shareholders Form for the redemption request for bonus preference shares Form for Waiving Dividend 2002-03 Board of Directors meet Notice of Board Meting EGM clears resolutions for split, buyback Public announcement of buyback 2001-02 Offer Letter to Shareholders-Regional Stock Exchanges delisting 2000-01 Merger/Amalgamation of Sun Pharmaceutical Advanced research company limited Financials Annual Reports Presentations FAQs Stock Price Chairman's Speech Shareholding Pattern Regulatory Compliance News Articles Contact Us SITE MAP   DISCLAIMER   PRIVACY POLICY   INTRANET    FIELD FORCE